查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1927696

全球生命科學分析人工智慧市場：按產品、部署方式、應用、最終用戶、國家和地區分類－產業分析、市場規模、佔有率和預測（2025-2032年）

AI In Life Science Analytics Market, By Offering, By Deployment Mode, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 310 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年，生命科學分析領域的 AI 市場規模將達到 21.053 億美元，從 2025 年到 2032 年的複合年成長率將達到 11.45%。

生命科學分析領域的人工智慧市場主要利用人工智慧（例如機器學習、自然語言處理和各種生成式人工智慧工具）來處理生命科學公司面臨的大量數據，並更有效率地做出更明智的決策。製藥和生物技術公司從各種來源收集數據，包括基因組學/體學研究、實驗室檢測、臨床試驗、安全報告、科學論文以及電子健康記錄(EHR) 和保險索賠數據等真實世界數據。挑戰在於，這些數據通常分散且非結構化（例如醫生筆記和醫學文獻）。人工智慧可以透過發現模式、預測結果和自動化分析任務來提供幫助，這些任務如果由人類完成則非常耗時。因此，人工智慧正擴大應用於各個領域，包括藥物發現、臨床試驗計劃和患者招募、藥物監測（副作用檢測）、真實世界證據研究、精準醫療，甚至銷售預測和供應鏈分析。

生命科學分析人工智慧的市場動態

政府主導的研發資金激增和臨床試驗的增加正在加速人工智慧在生命科學分析領域的應用。

推動生命科學分析領域人工智慧市場發展的主要因素之一是政府對生物醫學研發投入的不斷增加。同時，臨床研究數量的持續成長和追蹤意味著研究人員需要處理大量數據，這使得人工智慧分析從「錦上添花」變成了「必不可少」。根據美國國立衛生研究院 (NIH) 的數據，其 2023 會計年度的預算授權為 475 億美元，2024 財政年度將增加至 486 億美元。這筆資金支持了許多大型研究項目，這些項目會產生複雜的資料集（例如基因組數據和臨床數據），而這些資料集需要高級分析技術來處理。此外，根據美國政府審核局 (GAO) 稱，美國國立衛生研究院 (NIH) 用於人工智慧相關研究的支出授權將從 2018 會計年度的約 15 億美元增加到 2022 會計年度的約 23 億美元，這標誌著政府主導的人工智慧活動在醫療和科學領域的擴展，以及人工智慧工具在現實世界中應用案例的人工智慧工具增加。在臨床研究領域，根據 ClinicalTrials.gov（美國國家醫學圖書館，美國政府）的數據，2023 年註冊的研究數量超過約 47.7 萬項，預計 2024 年將達到約 50 萬項。這表明臨床研究正在快速發展，而處理如此大量研究的機構將需要人工智慧分析來處理諸如患者資料分類、安全訊號監測和快速發現洞見等任務。總體而言，2022 年至 2024 年政府公佈的這些數據顯示了一個明顯的趨勢：資助的研究和臨床試驗的增加產生了更多的數據，這直接推動了對基於人工智慧的生命科學分析的需求。

生命科學分析領域的人工智慧市場：細分分析

臨床試驗和雲端部署是推動生命科學分析領域人工智慧強勁需求的兩大細分市場，其驅動力來自指數級成長的數據量和對可擴展計算的需求。臨床研究活動的持續擴展，直接增加了需要清理、監控和報告的結構化和非結構化試驗資料量。根據美國國家醫學圖書館的ClinicalTrials.gov網站顯示，其註冊量在2024年超過50萬（高於2023年的40萬左右）。這表明試驗記錄和相關文件的數量穩步成長，而人工智慧分析正被廣泛應用於可行性評估、患者匹配、通訊協定監控和快速洞察生成。藥物安全監測也為臨床試驗和上市後監測帶來了另一個主要數據流。據美國食品藥物管理局(FDA) 稱，近年來，FDA不利事件報告系統 (FAERS) 每年接受超過 200 萬份不利事件報告，因此對人工智慧驅動的病例處理、重複檢測和訊號檢測的需求不斷成長，以應對規模化問題。

同時，基於雲端的部署非常適合生命科學分析，因為它們為大型資料集和模型訓練提供了靈活的儲存和運算能力。根據美國國家標準與技術研究院 (NIST) 的說法，聯邦雲端指南和定義（包括 SP 800-145 等出版物以及相關的雲端安全指南，這些指南將在 2020 年至 2024 年期間被積極引用）將繼續規範雲端使用和安全的基本要求，從而支持受監管的分析工作負載更廣泛地採用雲端環境。總體而言，臨床試驗數量的增加、安全性報告水準的提高以及標準化雲端框架的建立，將推動 2020 年至 2025 年間生命科學工作流程中人工智慧分析的廣泛應用。

生命科學分析人工智慧市場—區域分析

北美地區憑藉其高額的科學研究投入、大規模的臨床研究活動以及成熟的受監管醫療數據數位基礎設施，仍然是生命科學分析領域人工智慧最具吸引力的地區之一。根據美國國立衛生研究院 (NIH) 的數據，其預算授權將從 2021 會計年度的 429 億美元成長至 2022 會計年度的 450 億美元、2023 會計年度的 475 億美元和 2024 會計年度的 486 億美元，用於支持生物醫學研究。生物醫學研究通常會產生大量數據，需要自動化和進階分析。臨床研究的數量也清楚地顯示了對分析的巨大需求。根據美國國家醫學圖書館的 ClinicalTrials.gov 網站的數據，到 2024 年，註冊的研究數量將超過 50 萬項，這凸顯了臨床試驗相關資料集的規模之大，而人工智慧工具正被用於這些資料集的可行性分析、患者識別支援、監測和報告。上市後數據和安全性數據將進一步增加分析工作流程的壓力。據美國食品藥物管理局(FDA) 稱，FDA不利事件報告系統 (FAERS) 在 2020 年代每年接受超過 200 萬份不利事件報告，這推動了對人工智慧驅動的病例處理和訊號檢測的需求。

美國生命科學分析人工智慧市場—國家分析

由於美國政府投入的資金規模龐大且穩定，以及受監管的資料流，因此被視為該市場中最具潛力的單一國家。據美國國立衛生研究院 (NIH) 稱，其預算授權將在 2024 會計年度達到 486 億美元，延續了 2022 會計年度 450 億美元的成長勢頭。這為研究網路產生大規模臨床和體學資料集提供了支持。臨床試驗的規模也反映了研究活動的活躍程度。根據 ClinicalTrials.gov 數據顯示，到 2024 年，註冊試驗的總數將超過 50 萬項，這將支撐試驗計劃、運行監測和結果分析方面分析需求的持續成長。安全報告數量的不斷增加進一步強化了自動化技術的商業價值。據美國食品藥物管理局 (FDA) 稱，預計 2020 年代，藥品和醫療設備安全報告系統 (FAERS) 每年將收到超過 200 萬份報告，這將持續推動對人工智慧的需求，以輔助病例分診、發現說明文本中的模式并快速檢測安全訊號。

目錄

第1章 生命科學分析人工智慧市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：生命科學分析領域人工智慧的關鍵市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

4. 生命科學分析領域的人工智慧市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

第5章 生命科學分析人工智慧市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：生命科學分析人工智慧市場格局

  • 生命科學分析人工智慧市場佔有率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

7. 生命科學分析領域的人工智慧市場（依產品/服務分類）

  • 概述
    • 細分市場佔有率分析：透過提供
    • 軟體
    • 服務

第8章：生命科學分析人工智慧市場（以部署方式分類）

  • 概述
    • 細分市場佔有率分析：依部署方式
    • 基於雲端的
    • 本地部署

9. 生命科學分析人工智慧市場（按應用領域分類）

  • 概述
    • 細分市場佔有率分析：按應用
    • 藥物發現與開發
    • 臨床試驗
    • 銷售與行銷（商業分析）
    • 供應鍊和製造

第10章：生命科學分析人工智慧市場（以最終用戶分類）

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 製藥公司
    • 生技公司
    • CRO（委外研發機構）
    • 醫院、診所、研究機構

第11章：生命科學分析人工智慧市場（按地區分類）

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第12章 主要供應商分析：生命科學分析產業的AI

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Accenture
    • Amazon Web Services（AWS）
    • Capgemini
    • Cognizant
    • Databricks
    • Deloitte
    • Google（Google Cloud）
    • IBM
    • Infosys
    • IQVIA
    • Microsoft
    • NVIDIA
    • Oracle
    • Palantir Technologies
    • SAP
    • SAS
    • Snowflake
    • Tata Consultancy Services（TCS）
    • Tempus
    • Wipro
    • Others

第13章：分析師視角360度分析

簡介目錄
Product Code: ANV5922

AI in Life Science Analytics Market size was valued at US$ 2,105.3 Million in 2024, expanding at a CAGR of 11.45% from 2025 to 2032.

The AI in Life Science Analytics market primarily involves utilizing AI (such as machine learning, NLP, and various generative AI tools) to process the vast amount of data that life science companies encounter and to make informed decisions more efficiently. Pharma and biotech companies collect data from a lot of places like genomics/omics research, lab experiments, clinical trials, safety reports, scientific papers, and real-world data such as EHRs and insurance claims. The problem is that this data is messy and spread out, and a lot of it is unstructured (for example, doctor notes or medical literature). AI helps by finding patterns, predicting outcomes, and automating parts of analysis that would take humans way longer. That's why it's being used more in things like drug discovery, clinical trial planning and patient recruitment, pharmacovigilance (detecting side effects), real-world evidence studies, precision medicine, and even sales forecasting and supply chain analytics.

AI In Life Science Analytics Market- Market Dynamics

Surging Government-Backed R&D Funding and Clinical-Trial Volume Are Accelerating AI Adoption in Life Science Analytics

One big driver for the AI in Life Science Analytics market is that governments are putting more money into biomedical R&D, and, at the same time, the number of clinical studies being run and tracked keeps increasing so the amount of data researchers have to deal with is getting huge, and AI analytics becomes a practical need rather than a "nice to have." According to the U.S. National Institutes of Health (NIH), the NIH budget authority was $47.5 billion in FY2023 and increased to $48.6 billion in FY2024, which supports a lot of large research programs that generate complex datasets (like genomics and clinical data) that typically require advanced analytics. Also, according to the U.S. Government Accountability Office (GAO), NIH obligations for AI-related research rose from about $1.5 billion in FY2018 to about $2.3 billion in FY2022, showing that government-backed AI activity in health and science is expanding and creating more real use cases for AI tools. On the clinical research side, According to ClinicalTrials.gov (U.S. National Library of Medicine, U.S. government), there were over ~477,000 registered studies in 2023, and this went above ~500,000 studies by 2024, which basically shows how fast clinical research is scaling up; with that many studies, organizations need AI analytics to handle tasks like sorting patient data, monitoring safety signals, and finding insights faster. Overall, these 2022-2024 government-reported numbers point to a clear trend: more funded research plus more trials equals more data, and that directly boosts demand for AI-based life science analytics.

AI In Life Science Analytics Market- Segmentation Analysis:

Clinical trials and cloud-based deployment are two segments that strongly support demand in the AI in Life Science Analytics market because both are tied to fast-growing data volumes and the need for scalable computing. Clinical research activity keeps expanding, and that directly increases the amount of structured and unstructured trial data that must be cleaned, monitored, and reported. According to ClinicalTrials.gov (U.S. National Library of Medicine), the registry crossed 500,000+ registered studies in 2024 (rising from the high-400,000s in 2023), which signals a steady increase in trial records and related documentation where AI analytics is commonly used for feasibility, patient matching, protocol monitoring, and faster insight generation. Drug-safety monitoring adds another large data stream connected to trials and post-market surveillance; according to the U.S. Food and Drug Administration (FDA), the FDA Adverse Event Reporting System (FAERS) has been receiving over 2 million adverse event reports per year in recent years across the 2020s, creating ongoing demand for AI-driven case processing, duplicate detection, and signal detection to manage scale.

At the same time, cloud-based deployment fits life science analytics because it provides flexible storage and compute for large datasets and model training; according to the U.S. National Institute of Standards and Technology (NIST), federal cloud guidance and definitions (including publications actively referenced through 2020-2024, such as SP 800-145 and related cloud security guidance) continue to formalize baseline expectations for cloud usage and security, supporting broader adoption of cloud environments for regulated analytics workloads. Overall, rising clinical study counts, high safety-report volumes, and standardized cloud frameworks together support stronger use of AI analytics across life science workflows between 2020 and 2025.

AI In Life Science Analytics Market- Geographical Insights

North America remains one of the most attractive regions for AI in life science analytics because the region combines high research spending, large clinical research activity, and mature digital infrastructure for regulated health data. According to the U.S. National Institutes of Health (NIH), NIH budget authority increased from $42.9 billion (FY2021) to $45.0 billion (FY2022), then to $47.5 billion (FY2023) and $48.6 billion (FY2024), which supports a huge amount of data-producing biomedical research that typically needs automation and advanced analytics. Clinical research volume is also a strong signal of analytics demand; according to ClinicalTrials.gov (U.S. National Library of Medicine), the registry exceeded 500,000+ studies by 2024, highlighting the scale of trial-related datasets where AI tools are used for feasibility analytics, patient identification support, monitoring, and reporting. Post-market and safety data add even more pressure on analytics workflows; according to the U.S. Food and Drug Administration (FDA), the FDA Adverse Event Reporting System (FAERS) receives more than 2 million adverse event reports per year in the 2020s, which increases the need for AI-driven case processing and signal detection.

United States AI in Life Science Analytics Market- Country Insights

The United States is typically viewed as the strongest single-country opportunity in this market because government-backed spending and regulated data streams are unusually large and consistent. According to the NIH, budget authority reached $48.6 billion in FY2024, continuing growth from $45.0 billion in FY2022, and supporting research networks that generate large-scale clinical and omics datasets. Research activity is also reflected in clinical trial scale; according to ClinicalTrials.gov, total registered studies crossed 500,000+ in 2024, which supports steady demand for analytics across trial planning, operational oversight, and outcome analysis. Safety reporting volumes further strengthen the business case for automation; according to the FDA, FAERS receives 2 million+ reports annually in the 2020s, creating ongoing demand for AI that can triage cases, find patterns in narrative text, and support faster detection of safety signals.

AI In Life Science Analytics Market- Competitive Landscape:

The competitive landscape is shaped by the ability to manage regulated data at scale, connect multiple life science datasets, and deploy AI models in production with audit-ready governance. Major vendors typically referenced in this space include SAS (strength in statistical analytics and governance for regulated environments), IBM (strength in enterprise AI and NLP for unstructured text analytics), Oracle (strength in life-science data systems and scalable cloud infrastructure), Microsoft (strength in enterprise cloud and AI services with security controls), AWS (strength in elastic compute and data services for large-scale analytics), Google Cloud (strength in data engineering and AI/ML tooling at scale), IQVIA (strength in real-world data/real-world evidence and commercial analytics), and Veeva (strength in life-sciences workflows and commercial content/data management). Strong public indicators reported between 2020-2025 including rising NIH funding according to NIH, growing trial registration totals according to ClinicalTrials.gov, and high annual safety-report inflow according to FDA tend to favor vendors that can deliver compliant analytics, support high-volume pipelines, and integrate across clinical, safety, and R&D environments.

Recent Developments:

In December 2025, Medicus Pharma Ltd., a precision-guided biotech/life sciences company, announced a non-binding letter of intent (LOI) with Reliant AI Inc., a life-sciences decision-intelligence company focused on generative AI, to work on an AI-powered data analytics platform aimed at improving clinical trial execution using data-driven insights, with planned capabilities such as dynamic site selection, patient stratification, and enrollment forecasting, and an initial focus on dynamic site selection and targeted stratification for an upcoming Teverelix clinical study expected to begin in 2026.

In June 2025, IQVIA, a global provider of clinical research services, commercial insights, and healthcare intelligence for life sciences, unveiled new custom AI agents at GTC Paris built using NVIDIA technology to improve workflows and speed up insights, with use cases highlighted across target identification, clinical data review, literature review, market assessment, and HCP engagement, following a strategic collaboration announced in January to develop custom foundation models and agentic AI workflows to support research, clinical development, and treatment access.

In February 2025, Medidata (Dassault Systemes), a clinical development solutions provider for biopharma, reaffirmed its plan to expand AI and virtual-twin capabilities across the clinical development process, describing how generative experiences using synthetic data can simulate virtual patient cohorts to improve trial performance and reduce exposure to experimental therapies, and noting that Medidata works with 19 of the top 20 pharmaceutical companies while leveraging a large patient-level historical clinical trial dataset to support patient-centric trial and post-trial outcomes programs.

In June 2025, the U.S. Food and Drug Administration (FDA), the U.S. federal regulator for drugs and medical products, announced an agency-wide expansion of its internal generative AI tool Elsa by June 30, 2025, stating that the system runs in a secure GovCloud environment to help staff with clinical protocol assessments, safety evaluations, and internal workflow efficiency, and adding that Elsa does not train on regulated-industry-submitted data to protect confidential and proprietary information.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Accenture
  • Amazon Web Services (AWS)
  • Capgemini
  • Cognizant
  • Databricks
  • Deloitte
  • Google (Google Cloud)
  • IBM
  • Infosys
  • IQVIA
  • Microsoft
  • NVIDIA
  • Oracle
  • Palantir Technologies
  • SAP
  • SAS
  • Snowflake
  • Tata Consultancy Services (TCS)
  • Tempus
  • Wipro
  • Others

GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY OFFERING- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services

GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2019 - 2032

  • Cloud-based
  • On-premises

GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery & Development
  • Clinical Trials
  • Sales & Marketing (Commercial Analytics)
  • Supply Chain & Manufacturing

GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Hospitals/Clinics & Research Institutes

GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AI In Life Science Analytics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI In Life Science Analytics Market Snippet by Offering
    • 2.1.2. AI In Life Science Analytics Market Snippet by Deployment Mode
    • 2.1.3. AI In Life Science Analytics Market Snippet by Application
    • 2.1.4. AI In Life Science Analytics Market Snippet by End User
    • 2.1.5. AI In Life Science Analytics Market Snippet by Country
    • 2.1.6. AI In Life Science Analytics Market Snippet by Region
  • 2.2. Competitive Insights

3. AI In Life Science Analytics Key Market Trends

  • 3.1. AI In Life Science Analytics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI In Life Science Analytics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI In Life Science Analytics Market Opportunities
  • 3.4. AI In Life Science Analytics Market Future Trends

4. AI In Life Science Analytics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI In Life Science Analytics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. AI In Life Science Analytics Market Landscape

  • 6.1. AI In Life Science Analytics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI In Life Science Analytics Market - By Offering

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Offering, 2024 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services

8. AI In Life Science Analytics Market - By Deployment Mode

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Deployment Mode, 2024 & 2032 (%)
    • 8.1.2. Cloud-based
    • 8.1.3. On-premises

9. AI In Life Science Analytics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Drug Discovery & Development
    • 9.1.3. Clinical Trials
    • 9.1.4. Sales & Marketing (Commercial Analytics)
    • 9.1.5. Supply Chain & Manufacturing

10. AI In Life Science Analytics Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Deployment Mode, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotechnology Companies
    • 10.1.4. Contract Research Organizations (CROs)
    • 10.1.5. Hospitals/Clinics & Research Institutes

11. AI In Life Science Analytics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. AI In Life Science Analytics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. AI In Life Science Analytics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. AI In Life Science Analytics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. AI In Life Science Analytics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. AI In Life Science Analytics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- AI In Life Science Analytics Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Accenture
    • 12.2.2. Amazon Web Services (AWS)
    • 12.2.3. Capgemini
    • 12.2.4. Cognizant
    • 12.2.5. Databricks
    • 12.2.6. Deloitte
    • 12.2.7. Google (Google Cloud)
    • 12.2.8. IBM
    • 12.2.9. Infosys
    • 12.2.10. IQVIA
    • 12.2.11. Microsoft
    • 12.2.12. NVIDIA
    • 12.2.13. Oracle
    • 12.2.14. Palantir Technologies
    • 12.2.15. SAP
    • 12.2.16. SAS
    • 12.2.17. Snowflake
    • 12.2.18. Tata Consultancy Services (TCS)
    • 12.2.19. Tempus
    • 12.2.20. Wipro
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us